Physician profile
Calhoun D Cunningham
NPI 1699774000
$2,626.41
in general payments reported to CMS, 2019-2025
9 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $982 · 2021: $171 · 2022: $109 · 2023: $1,000 · 2024: $160 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $1,000 · Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $1,000.00 |
| Food and Beverage | $364.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Med-El Corporation | $1,623.75 | 2019-2023 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit |
| Stryker Corporation | $231.61 | 2019 | |
| Procept Biorobotics Corporation | $159.51 | 2024 | Aquabeam System |
| Advanced Bionics, LLC | $147.56 | 2019-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Oticon Medical, LLC | $124.38 | 2025 | Ponto Bone Anchored Hearing System |
| Ethicon INC. | $117.89 | 2021 | |
| Medtronic USA, INC. | $99.17 | 2019 | |
| Cochlear Americas | $74.62 | 2022 | |
| Glaxosmithkline, LLC. | $47.92 | 2025 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Calhoun Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.